Diverse effects of a Cyperus rotundus extract on glucose uptake in myotubes and adipocytes and its suppression on adipocyte maturation.

Cyperus rotundus 3T3-L1 adipocytes Adipogenesis Glucose transport L6 myotubes

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 Apr 2024
Historique:
received: 29 09 2023
accepted: 09 04 2024
medline: 20 4 2024
pubmed: 20 4 2024
entrez: 19 4 2024
Statut: epublish

Résumé

Cyperus rotundus rhizomes have been used in longevity remedies in Thailand for nourishing good health, which led us to investigate the effect on energy homeostasis, especially glucose utilization in myotubes and adipocytes, and on inhibition of lipogenesis in adipocytes. The results showed that an ethyl acetate extract of C. rotundus rhizomes (ECR) containing 1.61%w/w piceatannol, with a half-maximal concentration of 17.76 ± 0.03 μg/mL in 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, caused upregulation and cell-membrane translocation of glucose transporters GLUT4 and 1 in L6 myotubes but downregulation and cytoplasmic localization of GLUT4 expression in 3T3-L1 adipocytes and was related to the p-Akt/Akt ratio in both cells, especially at 100 μg/mL. Moreover, ECR (25-100 μg/mL) significantly inhibited lipid accumulation via Adenosine Monophosphate-Activated Protein Kinase (AMPK), Acetyl CoA Carboxylase (ACC), and Glycogen Synthase Kinase (GSK) pathways. Its immunoblot showed increased expression of p-AMPKα/AMPKα and p-ACC/ACC but decreased expression of p-Akt/Akt and p-GSK3β/GSK3β in 3T3-L1 adipocytes. Moreover, the decreased expression of the adipogenic effectors, perilipin1 and lipoprotein lipase, in ECR-incubated adipocytes (50 and 100 μg/mL) indicated reduced de novo lipogenesis. Our study elucidated mechanisms of C. rotundus that help attenuate glucose tolerance in skeletal muscle and inhibit lipid droplet accumulation in adipose tissue.

Identifiants

pubmed: 38641685
doi: 10.1038/s41598-024-59357-0
pii: 10.1038/s41598-024-59357-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9018

Subventions

Organisme : Fundamental Fund 2565, TSRI (Thailand)
ID : CUFRB65_hea(58)_067_33_11

Informations de copyright

© 2024. The Author(s).

Références

Zhao, X. et al. The crucial role and mechanism of insulin resistance in metabolic disease. Front. Endocrinol. 14, 1149239. https://doi.org/10.3389/fendo.2023.1149239 (2023).
doi: 10.3389/fendo.2023.1149239
Klein, S., Gastaldelli, A., Yki-Järvinen, H. & Scherer, P. E. Why does obesity cause diabetes?. Cell Metab. 34, 11–20. https://doi.org/10.1016/j.cmet.2021.12.012 (2022).
doi: 10.1016/j.cmet.2021.12.012 pubmed: 34986330 pmcid: 8740746
Batchuluun, B., Pinkosky, S. L. & Steinberg, G. R. Lipogenesis inhibitors: Therapeutic opportunities and challenges. Nat. Rev. Drug Discov. 21, 283–305. https://doi.org/10.1038/s41573-021-00367-2 (2022).
doi: 10.1038/s41573-021-00367-2 pubmed: 35031766 pmcid: 8758994
Chadt, A. & Al-Hasani, H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflug. Arch. 472, 1273–1298. https://doi.org/10.1007/s00424-020-02417-x (2020).
doi: 10.1007/s00424-020-02417-x
San, H. T. et al. Pinostrobin: An adipogenic suppressor from fingerroot (Boesenbergia rotunda) and its possible mechanisms. Foods 11, 3024. https://doi.org/10.3390/foods11193024 (2022).
doi: 10.3390/foods11193024 pubmed: 36230099 pmcid: 9564182
Khine, H. E. E., Sungthong, R., Sritularak, B., Prompetchara, E. & Chaotham, C. Untapped pharmaceutical potential of 4,5,4′-trihydroxy-3,3′-dimethoxybibenzyl for regulating obesity: A cell-based study with a focus on terminal differentiation in adipogenesis. J. Nat. Prod. 85, 1591–1602. https://doi.org/10.1021/acs.jnatprod.2c00213 (2022).
doi: 10.1021/acs.jnatprod.2c00213 pubmed: 35679136
Savova, M. S., Mihaylova, L. V., Tews, D., Wabitsch, M. & Georgiev, M. I. Targeting PI3K/AKT signaling pathway in obesity. Biomed. Pharmacother. 159, 114244. https://doi.org/10.1016/j.biopha.2023.114244 (2023).
doi: 10.1016/j.biopha.2023.114244 pubmed: 36638594
Raut, N. A. & Gaikwad, N. J. Antidiabetic activity of hydro-ethanolic extract of Cyperus rotundus in alloxan induced diabetes in rats. Fitoterapia 77, 585–588. https://doi.org/10.1016/j.fitote.2006.09.006 (2006).
doi: 10.1016/j.fitote.2006.09.006 pubmed: 17056202
Shi, Y. et al. Study on the quality difference of Cyperus rotundus before and after vinegar processing based on ultra-high-performance liquid chromatography-quadrupole-time of flight-mass spectrometry and molecular network combined with color parameters. J. Sep. Sci. 46, 2200990. https://doi.org/10.1002/jssc.202200990 (2023).
doi: 10.1002/jssc.202200990
Kraithep, S., Oungbho, K. & Tewtrakul, S. Anti-allergic activity of Thai medicinal plants used in longevity formulation. Songklanakarin J. Sci. Technol. 30, 621–625 (2008).
Singh, P., Khosa, R. L., Mishra, G. & Jha, K. K. Antidiabetic activity of ethanolic extract of Cyperus rotundus rhizomes in streptozotocin-induced diabetic mice. J. Pharm. Bioallied. Sci. 7, 289–292. https://doi.org/10.4103/0975-7406.168028 (2015).
doi: 10.4103/0975-7406.168028 pubmed: 26681885 pmcid: 4678986
Majeed, M. et al. The anti-obesity potential of Cyperus rotundus extract containing piceatannol, scirpusin A and scirpusin B from rhizomes: Preclinical and clinical evaluations. Diabetes Metab. Syndr. Obes. 15, 369–382. https://doi.org/10.2147/DMSO.S348412 (2022).
doi: 10.2147/DMSO.S348412 pubmed: 35177914 pmcid: 8843772
Stella, L. et al. Collisionally induced fragmentation of [M-H]
doi: 10.1002/rcm.3811 pubmed: 18980255
Jeong, S. J., Miyamoto, T., Inagaki, M., Kim, Y. C. & Higuchi, R. Rotundines A-C, three novel sesquiterpene alkaloids from Cyperus rotundus. J. Nat. Prod. 63, 673–675. https://doi.org/10.1021/np990588r (2000).
doi: 10.1021/np990588r pubmed: 10843585
Ludwig, D. S. et al. Competing paradigms of obesity pathogenesis: Energy balance versus carbohydrate-insulin models. Eur. J. Clin. Nutr. 76, 1209–1221. https://doi.org/10.1038/s41430-022-01179-2 (2022).
doi: 10.1038/s41430-022-01179-2 pubmed: 35896818 pmcid: 9436778
Ardestani, A. & Yazdanparast, R. Cyperus rotundus suppresses AGE formation and protein oxidation in a model of fructose-mediated protein glycoxidation. Int. J. Biol. Macromol. 41, 572–578. https://doi.org/10.1016/j.ijbiomac.2007.07.014 (2007).
doi: 10.1016/j.ijbiomac.2007.07.014 pubmed: 17765965
Cohen, G., Riahi, Y. & Sasson, S. Free radicals and metabolic disorders in In Encyclopedia of Radicals in Chemistry, Biology and Materials (eds. Chatgilialoglu, C. & Studer, A.) (Wiley, 2012) https://doi.org/10.1002/9781119953678.rad057 .
Khutami, C., Sumiwi, S. A., Khairul Ikram, N. K. & Muchtaridi, M. The effects of antioxidants from natural products on obesity, dyslipidemia, diabetes and their molecular signaling mechanism. Int. J. Mol. Sci. 23, 2056. https://doi.org/10.3390/ijms23042056 (2022).
doi: 10.3390/ijms23042056 pubmed: 35216172 pmcid: 8875143
Minakawa, M., Miura, Y. & Yagasaki, K. Piceatannol, a resveratrol derivative, promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and suppresses blood glucose levels in type 2 diabetic model db/db mice. Biochem. Biophys. Res. Commun. 422, 469–475. https://doi.org/10.1016/j.bbrc.2012.05.017 (2012).
doi: 10.1016/j.bbrc.2012.05.017 pubmed: 22579688
Tung, Y.-C. et al. Piceatannol exerts anti-obesity effects in C57BL/6 mice through modulating adipogenic proteins and gut microbiota. Molecules 21, 1419. https://doi.org/10.3390/molecules21111419 (2016).
doi: 10.3390/molecules21111419 pubmed: 27792146 pmcid: 6273354
Carpéné, C. et al. The dietary antioxidant piceatannol inhibits adipogenesis of human adipose mesenchymal stem cells and limits glucose transport and lipogenic activities in adipocytes. Int. J. Mol. Sci. 19, 2081. https://doi.org/10.3390/ijms19072081 (2018).
doi: 10.3390/ijms19072081 pubmed: 30018277 pmcid: 6073844
Huang, X., Liu, G., Guo, J. & Su, Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int. J. Biol. Sci. 14, 1483–1496. https://doi.org/10.7150/ijbs.27173 (2018).
doi: 10.7150/ijbs.27173 pubmed: 30263000 pmcid: 6158718
Sarabia, V., Lam, L., Burdett, E., Leiter, L. A. & Klip, A. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. J. Clin. Invest. 90, 1386–1395. https://doi.org/10.1172/JCI116005 (1992).
doi: 10.1172/JCI116005 pubmed: 1401073 pmcid: 443184
Kozka, I. J. & Holman, G. D. Metformin blocks downregulation of cell surface GLUT4 caused by chronic insulin treatment of rat adipocytes. Diabetes 42, 1159–1165. https://doi.org/10.2337/diab.42.8.1159 (1993).
doi: 10.2337/diab.42.8.1159 pubmed: 8325447
Boyle, J. G. et al. AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: A randomised glycaemia-controlled crossover study. Diabetologia 54, 1799–1809. https://doi.org/10.1007/s00125-011-2126-4 (2011).
doi: 10.1007/s00125-011-2126-4 pubmed: 21455728
Miao, R. et al. Akt: A potential drug target for metabolic syndrome. Front. Physiol. 13, 822333. https://doi.org/10.3389/fphys.2022.822333 (2022).
doi: 10.3389/fphys.2022.822333 pubmed: 35330934 pmcid: 8940245
Beg, M., Zhang, W., McCourt, A. C. & Enerbäck, S. ATGL activity regulates GLUT1-mediated glucose uptake and lactate production via TXNIP stability in adipocytes. J. Biol. Chem. 296, 100332. https://doi.org/10.1016/j.jbc.2021.100332 (2021).
doi: 10.1016/j.jbc.2021.100332 pubmed: 33508319 pmcid: 7949114
Garcia, D. & Shaw, R. J. AMPK: Mechanisms of cellular energy sensing and restoration of metabolic balance. Mol. Cell. 66, 789–800. https://doi.org/10.1016/j.molcel.2017.05.032 (2017).
doi: 10.1016/j.molcel.2017.05.032 pubmed: 28622524 pmcid: 5553560
Kopietz, F. et al. Inhibition of AMPK activity in response to insulin in adipocytes: Involvement of AMPK pS485, PDEs, and cellular energy levels. Am. J. Physiol. Endocrinol. Metab. 319, E459–E471. https://doi.org/10.1152/ajpendo.00065.2020 (2020).
doi: 10.1152/ajpendo.00065.2020 pubmed: 32663099
Konige, M., Wang, H. & Sztalryd, C. Role of adipose specific lipid droplet proteins in maintaining whole body energy homeostasis. Biochim. Biophys. Acta Mol. Basis Dis. 393–401, 2014. https://doi.org/10.1016/j.bbadis.2013.05.007 (1842).
doi: 10.1016/j.bbadis.2013.05.007
Mead, J. R., Irvine, S. A. & Ramji, D. P. Lipoprotein lipase: Structure, function, regulation, and role in disease. J. Mol. Med. 80, 753–769. https://doi.org/10.1007/s00109-002-0384-9 (2002).
doi: 10.1007/s00109-002-0384-9 pubmed: 12483461
Kim, K. H. et al. Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c. J. Biol. Chem. 279, 51999–52006. https://doi.org/10.1074/jbc.M405522200 (2004).
doi: 10.1074/jbc.M405522200 pubmed: 15466874
Suzuki, T. et al. Inhibition of AMPK catabolic action by GSK3. Mol. Cell. 50, 407–419. https://doi.org/10.1016/j.molcel.2013.03.022 (2013).
doi: 10.1016/j.molcel.2013.03.022 pubmed: 23623684 pmcid: 3654099
Park, Y. J., Lee, G. S., Cheon, S. Y., Cha, Y. Y. & An, H. J. The anti-obesity effects of Tongbi-san in a high-fat diet-induced obese mouse model. BMC Complement. Altern. Med. 19, 1. https://doi.org/10.1186/s12906-018-2420-5 (2019).
doi: 10.1186/s12906-018-2420-5 pubmed: 30606178 pmcid: 6319014
Kwon, J. Y. et al. Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation. J. Biol. Chem. 287, 11566–11578. https://doi.org/10.1074/jbc.M111.259721 (2012).
doi: 10.1074/jbc.M111.259721 pubmed: 22298784 pmcid: 3322826
Park, I. S., Han, Y., Jo, H., Lee, K. W. & Song, Y. S. Piceatannol is superior to resveratrol at suppressing adipogenesis in human visceral adipose-derived stem cells. Plants Basel 10, 366. https://doi.org/10.3390/plants10020366 (2021).
doi: 10.3390/plants10020366 pubmed: 33672932 pmcid: 7918058
Chansriniyom, C. et al. A synergistic combination of Phyllanthus emblica and Alpinia galanga against H
doi: 10.1016/j.jff.2018.01.016
Shao, B. et al. Simultaneous determination of six major stilbenes and flavonoids in Smilax china by high performance liquid chromatography. J. Pharm. Biomed. Anal. 44, 737–742. https://doi.org/10.1016/j.jpba.2007.03.008 (2007).
doi: 10.1016/j.jpba.2007.03.008 pubmed: 17475435
Rodriguez-Lanzi, C. et al. Grape pomace extract supplementation activates FNDC5/irisin in muscle and promotes white adipose browning in rats fed a high-fat diet. Food Funct. 11, 1537–1546. https://doi.org/10.1039/c9fo02463h (2020).
doi: 10.1039/c9fo02463h pubmed: 31998896

Auteurs

Vipawee Pichetkun (V)

Pharmaceutical Sciences and Technology Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Center of Excellence in Natural Products and Nanoparticles (NP2), Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.

Hnin Ei Ei Khine (HEE)

Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Preclinical Toxicity and Efficacy Assessment of Medicines and Chemicals Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.

Suchada Srifa (S)

Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Preclinical Toxicity and Efficacy Assessment of Medicines and Chemicals Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.

Sasiwimon Nukulkit (S)

Center of Excellence in Natural Products and Nanoparticles (NP2), Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.

Nitra Nuengchamnong (N)

Science Laboratory Center, Faculty of Science, Naresuan University, Phitsanulok, 65000, Thailand.

Supakarn Hansapaiboon (S)

Pharmaceutical Research Instrument Center of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.

Rattaporn Saenmuangchin (R)

National Nanotechnology Center, National Science and Technology Development Agency, 111 Phahonyothin Rd., Klongluang, Pathumthani, 12120, Thailand.

Chatchai Chaotham (C)

Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. chatchai.c@chula.ac.th.
Preclinical Toxicity and Efficacy Assessment of Medicines and Chemicals Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. chatchai.c@chula.ac.th.

Chaisak Chansriniyom (C)

Center of Excellence in Natural Products and Nanoparticles (NP2), Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. chaisak.ch@chula.ac.th.
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. chaisak.ch@chula.ac.th.

Classifications MeSH